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,Sixty Chinese patients on lithium treatment were interviewed from September 1997 to 
•V February 1998. All patients who participated in the present study were identified at the 
outpatient clinic of a large regional liospital in Hong Kong through convenient sampling 
irrespective of their adherence status. Information gathered in the interview included: 
self-report adherence status, demography, illness and medication variables, attitude 
variables, and selfperceived support from the family. Multiple criteria of serum lithium 
level, patients' self report, family member' s report and doctor' s report were used to 
determine patients' adherence in the past one year. A non-adherence rate o f73% was 
found. Among the variables, young age, denial ofillness severity, being employed and 
lithium monotherapy were found to be important factors in differentiating the adherent 
and non-adherent group. However, attribution of mental distress, health locus of 
control, and perceived support from the family failed to differentiate the adherent and 
non-adherent group. In light of patients' denial of illness severity, more 
psychoeducation about the nature of illness and the need of medication for both the 
patients and their family is needed. Furthermore, the underlying reasons for denial 
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Drug Adherence 1 
Chapter 1 
Introduction ahd Literature Review 
i � 
/ 
The present study aimed at examining the psychosocial correlates o fdrug 
V 
adherence and identifying the most informative predictors of non-adherence. It was 
expected the findings would be helpful in determining the future direction for 
promoting patients' adherence to the medication. In addition, by examining the 
relation among various measurements of medication adherence, it was expected to 
fmd a most appropriate way to determine the patients，adherence in the clinical 
setting. 
Adherence (Compliance) 
Compliance is defined by Haynes as the extent to which the patients’ behavior 
(in terms of taking medications, following diets, or executing lifestyle changes) 
coincides with medical or health advice (0'Hanrahan and 0'Malley, 1981; Evans & 
Spelman, 1983). However, Frank, Perel, Mallinger, Thase, and Kupfer (1992) 
tended to emphasize the concept of"adherence" rather than ‘‘compliance，，in their 
work with patients. Frank and colleagues found that the term "adherence，，connoted a 
more participatory position on the part of the patient. In the present study, the concept 
of"adherence" is used, which refers to the extent to which patient takes the 
medication as prescribed. 
Pattern of Non-adherence 
The increasing numbers of effective drugs which have been made available 
during the past few decades have caused issues of adherence and non-adherence to 
become much more important (Evans & Spdman，1983). The patterns of medication 
non-adherence vary, including taking fewer doses than prescribed, taking the correct 
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total daily dosage but not in the proper dosing pattern, taking more than the prescribed 
daily dosage, and total abandonment (Kane, 1985). 
I 、 
/ 
Health BeIiefModel and Adherence-Related Attitudes 
s 
People's adherence-related attitude can be explained by the Health Belief 
Model (HBM). Ludwig, Huber, Schmidt, Bender, & Greil (1990) summarized the 
model as follows. Patients weigh disadvantages or costs of their treatment (negative 
side effects, necessitated behavior changes, etc.) against its benefits (positive effects 
011 health and social functioning) and will follow the prescribed treatment if they 
conclude that its benefits outweigh the cost. Also, the more patients view themselves 
threatened by an illness, due to its seriousness or their susceptibility to it, the more 
likely patients are assumed to behave compliantly, since benefits from treating an 
illness increase when the amount of threat or suffering can be prevented or reduced by 
the treatment. 
Non-Adherence and Psychiatric Disorders 
As widespread a problem as it is in chronic health problems (e.g. high blood 
pressure, diabetes, astluna, and arthritis, etc.), non-adherence may be an even more 
extensive and more complex issue in psychiatric disorders, as the nature of patient's 
illness may have strong effect onjudgment, insight and stability. For instance, manic 
patients may deny the illness or actively resist the need of medication, paranoid 
schizophrenics may consider treatment with suspicion, and those with profound 
depression may lack motivation to take the medication. Estimated non-adherence 
rates of 40 to 50% are common among psychiatric outpatients (Kane, 1985). More 
important is that medication non-adherence was found to be highly correlated with 
frequent re-hospitalization of psychiatric patients (Green, 1988). 
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Drug Adherence and AiTcctive Disorder 
Bipolar Disorder and Lithium 
Lithium is well established as an effective prophylactic in management of ^ 
/ 
recurrent affective disorders, especially for bipolar disorder. Bipolar disorder (manic-
� . 
depressive disorder) is defined in Diagnostic and Statistical Manual ofAmerican 
Psychiatric Association, 4^ '^  edition (DSM-IV) by the criterion of the patient having 
suffered at least one manic, hypomanic or mixed episode. Most patients experience 
relatively few side effects under the lithium treatment, and the seriousness of the 
illness per se often makes the patients and the treating physician apt to tolerate 
substantial side effects when they do appear (Nilsson & Axelsson, 1989). 
Hopkins & Gelenberg (1994) summarized that lithium lessens the duration, 
severity of episodes of mania and depression, and decreases the risk of subsyndromal 
symptoms between episodes, and reduces the risk of mortality. Muller-
Oerlinghausen and colleagues (1992) found that the mortality rate of manic-depfessive 
patients was 2 to 3 times that of the general population. Yet, the mortality rate for 827 
manic-depressive and schizoaffective patients given lithium treatment for more than 6 
months was not significantly different from that of general population. 
Isometsa, Henriksson, and Lonnqvist (1992) suggested that the problem of 
adherence might limit the usefulness of the lithium treatment in suicide prevention. 
Isometsa and colleagues (1992) found that in a population representative ofaIl 
suicides of lithium-related patients in one year in Finland, less than 50% ofthe 
victims fulfilled the criteria of recent adequate lithium prophylaxis, and 85% was 
reported to have been intermittently or continuously non-adherent with 
psychopharmacological treatment in two years. 
Suppes, Baldessarinin, and Faedda (1991) reviewed 14 studies involving 257 
patients with first-episode bipolar disorder. The review indicated that more than 50% 
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of patients who discontinued the lithium maintenance treatment experienced a 
recurrent mood episodes ofillness within three months of stopping lithium treatment. 
Such a high recurrence rate appeared t6 be higher than those expected from the ' f 
spontaneous recurrence rate in untreated bipolar illness. Keck and colleagues (1996) 
V 
assessed adherence in 101 patients (with bipolar disorder, manic or mixed, and 
schizoaffective disorder) hospitalized for acute mania using a clinician-administered 
questionnaire, ln this study 64% patients were non-adherent with their 
pharmacological regimen in the month prior to admission. Continued adherence 
appeared to have critical importance to the effective management ofrecurrent 
affective disorder. 
As mentioned before, non-adherence is an extensive problem in psychiatric 
disorder. Lithium non-adherence is also a pervasive problem in the effective 
treatment of manic-depressive disorders. Cochran and Gitlin (1988) reviewed that 
about 20% to 66% of lithium patients were estimated to experience difficulties 
adhering to lithium regimens. More recent estimate by Keck, McElroy, Strakowski, 
Burne, and West (1997) from the studies indicated that the prevalence of non-
adherence in outpatients with bipolar disorder treated with lithium ranged from 12 to 
60%. Therefore, the seriousness of drug non-adherence cannot be neglected. 
Methods for Assessing A d/ierence 
The differences in the prevalence of non-adherence (i.e. 12 to 66%) may partly 
be due to the differences among these studies in the definition, assessment ofnon-
adherence, and of duration of follow up (Goodwin & Jamison，1990). Discrepancy 
was found between different measures. For instance, Kucera-Bozarth, Beck, and Lyss 
(1982) found 45% of the sample reported adherence in self-report but actually were 
non-adherent based on the lithium level criteria. The unreliability of self-report 
measure was highlighted further by the fact that 9% of sample reported non-adherence 
but actually were adherent when serum lithium value was examined. 
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The common approaches of adherence measurement methods, their 
differences，strengths, limitations were reviewed as follows (c.f. 0 'Hanrahan 8c 
0'Malley, 1981, Westfall, 1986). Indirect measure of non-adherence included s e l f - ‘ 
report, provider's report, and pill counting. Self reporting is an approach that secures 
\ . 
information directly from the patient. It is relatively simple, practical measure to use. 
It may be structured or unstructured, ranging from response to general questions to 
those obtained through a precisely developed interview guide. However, there is a 
tendency for adherent behavior to be exaggerated or over-reported and non-adherent 
behavior to be underestimated. Though this method lacks precision, it may be more 
sensitive for patients who have a great deal of deviation from the advised regimen. 
Ease and access are two strengths of health care provider reporting approach. 
However, physicians' estimates of patient adherence yield little more than chance 
levels of accuracy. Besides, subjectivity of such approach is apparent. This probably 
may limit the usefulness of this method. An estimate of adherence may be obtained at 
clinic visit by counting the number of tablets remaining. The usefulness of pill 
counting method depends on being able to determine how many tablets were 
originally dispensed. The more devious patient may adjust the number oftablets to 
appear adherent. Electronic medication monitors providing a record of the removal of 
tablets from the container is also available in some countries. Adherence may be 
measured directly by determining the blood concentration of the drug. Drugs with a 
long halflife give lhe steady state ofplasma concentrations of such drugs reflecting 
adherence over the previous week or more may provide useful information of 
adherence. Since the plasma concentrations only reflect adherence over previous few 
weeks or less, non-adherent patients who only take the medication before the week of 
blood test may not be detected by the blood test. Since no single method was perfect 
and there was discrepancy among different methods, multiple criteria was chosen by 
some studies(Kucera-Bozarth, Beck, and Lyss, 1982; Cochran, 1984; Lee, 1993; 
Kecket al. 1997). 
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Clinical Factors Associated with Lithium Non-adherence 
Keck and colleagues (1997) reviewed the important clinical factors associated 
with lithium non-adherence. The clinical factors are divided into four categories: 
V 
patient-related, illness-related, medication related and physician related. However, it 
should be noted that not all studies have found similar factors associated with lithium 
non-adherence, and some studies have examined some factors but not others. 
Patient-related factors included: young age, male gender, being single or 
unmarried, low level of education, low socioeconomic status, parental death or 
divorce in childhood, perceived loss of internal locus of control, and the lack of 
knowledge about the illness. (Keck et al. 1997). 
Young age as a factor associated with non-adherence was found in both 
western and local studies (Danion et al. 1987; Lee, 1993). According to Lee's 
explanation (1993), mental disorder was often equated with craziness and highly 
stigmatized in Chinese societies such as Hong Kong. Therefore, disorder which 
requires long term treatment undoubtedly might have strong negative impact on those 
young Chinese patients. This finding was consistent with his clinical experience that 
young patients with an earlier onset of illness were more inclined to deny their illness, 
not commit to lithium carbonate and fail to attend the blood tests. 
Kiicera-Bozarth, Beck and Lyss (1982) assessed the adherence of37 aduIt 
patients on lithium carbonate. In this study, non-adherent patients tended to be from 
lower socioeconomic class and were less likely to hold an internal Multidimensional 
Health Locus of Control (MHLC). It is expected that if the patients' locus of control 
was internal, their sense of responsibility for their own health would led them to 
adhere to the medication regimen. 
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Aagaard, Vestegaard, and Maarbjerg (1988) reported a multivariate predictor 
analysis of patients who discontinued lithium treatment during the first 6 months. The 
most informative predictors were: mariy earlier admissions to psychiatric hospital, and 
/ 
death or divorce of parent in childhood. 
； V 
I 
Keck and colleagues (1996) assessed adherence in 101 patients (with bipolar 
disorder, manic or mixed, and schizoaffective disorder) hospitalized for acute mahia 
using a clinician-administered questionnaire. In this study 65 patients (64%) were 
non-adherent with their pharmacological regimen in the month prior to admission. 
Among the reasons for partial or total non-adherence, denial ofillness was the most 
commonly cited one. 
Kane (1985) suggested that the nature of the patient's illness might affect 
judgment, insight and stability. Patients may deny their illness and / or view 
medication with a sense of mistrust or loss of control. Manic patients may deny illness 
or actively resist the need for medication. Those patients with profound depression 
may be too discouraged to take the drugs even those measures are beneficial. A lack 
of understanding of one's illness and the need for continuous medication, especially 
while the patient is in a state of remission and not feeling ill, contributes to the 
problem of non-adherence. Some of the patients may perceive that their illness is 
solely due to certain life crises or emotional concerns for example, the loss o f a j o b , 
the ending of a relationship with a significant others, difficulties with an authority 
figure and fail to understand the need for and the value of maintenance 
psychopharmacological treatment once the crisis is past or the situation ameliorated. 
Illness-related factors included: early age of onset, recent diagnosis ofbipolar 
disorder, great number of hospitalizations, fewer episodes ofbipolar iIIness, elevated 
mood, missing positively regarded symptoms, rapid cycling ofbipolar illness, bipolar 
Drug Adherence 8 
I rather than bipolar II disorder, cigarette smoking, comorbid substance use disorder, 
and comorbid personality disorder (Keck, et al., 1997). 
t “ 
Many earlier admissions to psychiatric hospital since the first presentation of 
s 
illness were significantly associated with non-adherence during 6-months，and 2-
years’ duration as shown in studies (Aagaard, Vestegaard, and Maarbjerg, 1988; 
Aagaard and Vestergaard, 1990). In addition, if substance abuse of drug or alcohol 
had occurred, an increased risk of non-adherence was found. Smokers as well as 
heavy smokers were significantly more likely to show non-adherence. 
Medication-related factors included: side effects，duration oflithium treatment, 
patient-perceived lack of efficacy, and medication symbolizing illness (Keck, et al., 
1997). 
Perceived side effects of lithium were the major clinical reason for 
discontinuing treatment in findings based on the western studies QSfilsson, & 
Axelsson, 1989; Gitlin, Cochran & Jamison，1989). Nilsson and Axelsson ( 1 9 8 9 ) 
followed 64 outpatients with major affective disorder and on continuous lithium 
treatment for 7 years, they found that side effects oflithium were the major clinical 
reason for discontinuing treatment. Approximately one fourth of the patients who 
discontinued lithium were differentiated from those who continued treatment by 
showing high frequency of the neurological side effects of incoordination, 
paraesthesia, and disturbed sensibility in addition to having more severe tremor. 
Gitlin et al. (1989) also indicated that self reported non-adherence correlated most 
highly with coordination (e.g. poor coordination, poor balance, trenior, dizziness, etc.) 
and cognition (e.g. poor concentration, memory problems, mental slowness, etc.). 
Among the side effects of lithium therapy, cognitive side effects and weight gain were 
the most disturbing to patients. More recent review by Silverstone and Romans 
(1996) also indicated that non-adherence was largely due to intolerance of adverse 
I . 
effects such as perceived menlal sluggishness, thirst, polyuria, and weight gain. 
Drug Adherence 9 
In addition to side effects, dosage schedule may be considered by patients as 
associated with adherence. Warner, Silk, Yeaton, Bargal, Janssen, & Hill (1994) 
/ 
studied the factors which perceived by psychiatric patients with mood disorder as 
\ 
associated with medication adherence. Among the 93 patients, 73% ofpatients 
reported that they adhered to the prescriptions if they thought the medication was 
efficacious. Manageable dosage schedule (33%) and minimal side effects (33%) 
ranked distant seconds, followed by history of adherence (27%) and personality of the 
patient (22%) were factors that identified as supporting adherence. However, factors 
that associated with non-adherence were somewhat different. Side effects were the 
most frequent reason for non-adherence (65%), the next was the lack ofdaily routine 
(40%), followed by patients' personality (28%) and beliefs about inefficacy (22%). 
And only 15% patients reported that complex dosage schedule might interfere with 
adherence. From the results, it is speculated that simple dosage schedule or regimen 
may promote adherence, but complex dosage schedule or regimen may not be an 
important factor in non-adherence behavior of the patients. 
Lastly, two physician-related factors have been associated with improved 
adherence which included: endorsement of treatment and continuity of care (Keck et 
al. 1997). Cochran and Gitlin's findings (1988) suggest that, if a patient reports that 
； . 
his or her psychiatrist believes in the regimen, and if the patient is motivated to do as 
expected by the physician, then the patient will have more positive attitudes toward 
lithium treatment, will report more intention to comply with the regimen, and will, in 
fact, report greater adherence with lithium treatment. 
Drug Adherence of Hong Kong Chinese Patients with Affective Disorder 
The medication adherence studies among the Chinese psychiatric patients are 
very limited. Based on the multiple criteria of serum lithium level, patients’ 
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subjective report and doctors，impression, the non-adherence rate o f 3 0 % was found 
• 
among 50 Chinese psychiatric patients on chronic lithium treatment in Hong Kong 
(Lee, 1993). Results of this study showed that only lithium monotherapy, younger ‘ 
i 
age, and earlier age of onset were significantly associated with non-adherence. In 
s 
addition, familiar western rationales for legitimating lithium non-adherence, such as 
missing highs, loss of assertiveness, loss of creativity, and excessive fear of weight 
gain, were rarely encountered in this study. A survey of these 50 patients showed 
about 48% of them reported that they did not know the common side effects of 
lithium and 88% of the patients did not know the warning signs ofIithium toxicity 
(Lee, Wing & Wong, 1992). It seemed that lithium adherence of Chinese psychiatric 
patients in Hong Kong was apparently not affected by the patients' drug knowledge. 
The reviev^ of various previous studies failed to find any factor to influence the 
adherence in any systematic way. Previous local study emphasized on the comparison 
of demographic and clinical variables. The present study would try t6 explore the 
influence of attitude-related variables and socio-cultural factors on the adherence of 
the patients with affective disorder. It was expected to identify the attitudes that 
related to the patients' non-adherence. The findings might be useful for directing the 
future trend for promoting the psychiatric patients' medication adherence. 
Individual Factors 
Attitude and Belief 
As mentioned before, adherence-related behavior can be explained by the 
Health BeliefModel (HBM). Connelly and colleagues (1982) applied the HBM in 
the lithium adherence research. The research tried to investigate the relationship 
between adherence and the patient's perceptions of illness, treatment, mood state, and 
side effects. Results indicated elevated mood was associated with overall non-
adherence. Marriage was associated with adherence to drug regimen, and perception 
of continuity of care was associated with appointment-keeping adherence. 
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According to the theory of reasoned action model (TRA) (Ajzen and Fishbein, 
.. •  
1980)，behavioral intentions are the proximal determinants of people's actions. It 
！ 
assumes that people are rational beihgs who systematically use available in format ion� 
, / I 
to shape their actions in the world. The theory hypothesizes that attitudes affect 
i \. * * • * 
behavior primarily through their shaping of behavioral intentions. These intentions 
are a function of two factors, one reflecting behavioral attitudes and the other 
reflecting the effects of social influence. Behavioral attitudes toward the activity in 
question simply the individiial's positive or negative evaluative judgments about 
performing the behavior. These attitudes, in turn, are a function ofbehavioral beliefs. 
Behavioral intentions are also shaped by perceptions of social pressures to perform the 
behavior in question. These perceived social prescriptions are referred to as 
subjective norms. They are a function ofbeliefs，but in this instance the beliefs are 
about what specific other individuals or groups who are important to the person in 
question expect the individual to do. The relative weighting ofbehavioral attitudes 
and subjective norms will ultimately determine whether or not the patient intends to 
comply and thus adhere to the treatment regimen, (c.f. Cochran 8c Gitlin，1988). 
Cochran and Gitlin (1988) applied this model to understand the relationship 
between lithium attitudes and adherence behaviors in a questionnaire study oflithiiim 
outpatients. The study found that lithium patients' normative beliefs (believe that 
relevant others such as family, friends, personal psychiatrist, and lithium experts want 
the patient to take lithium) predicted patients' subjective norms (the patients' 
expectation that others want the patients to take lithium). Both the subjective norm 
and evaluative behavioral attitudes about the positive nature of lithium treatment 
predicted patients' reported intent to adhere with the medication regimen. In turn, this 
behavioral intent predicted concurrent self-reported adherence with the medication 
regimen. This finding suggests that lithium non-adherence may be a predictable 
outcome of attitudes and beliefs. 
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The theory of planned behavior (TPB) (Ajzen, .1991) was developed as a 
deliberate attempt to broaden the applicability of the TRA (Ajzen and Fishbein, 1980) 
to include such non-volitional behavioVs by incorporating explicit considerations of ’ 
/ 
perceptions of control over performance of the behavior as an additional predictor of 
\ 
behavior. The TPB depicts behavior as a linear regression function of behavioral 
intentions and perceived behavioral control (B =wi BI + w2 PBC) where B is behavior, 
BI is behavioral intention, PBC is perceived behavioral control. The link between 
intention and behavior reflects the fact that people tend to engage in behaviors that 
they intend to perform. However, the relationship between behavior and PBC is more 
complex. This relationship suggests that we are more likely to engage in 
(attractive/desirable) behaviors we have control over (and suggests that we are 
prevented from carrying out behaviors over which we have no control). The TRA 
suggests behavioral attitudes and subjective norms are two predictors ofbehavioral 
intentions. The TPB incorporates a third predictor of intentions, perceived behavioral 
control, which is the individual's perception of the extent to which performance of the 
behavior is easy or difficult. The concept is similar to the concept ofseIf-efficacy, 
Control is seen as a continuum with easily executed behaviors at one end and 
behavioral goals demanding resources, opportunities and specialized skills at the other 
end. According to the TPB, attitude is determined by perceptions of the likelihood of 
salient outcomes and their evaluation. Subjective norm is determined by normative 
beliefs and motivation to comply with salient referents. Perceived behavioral control 
is determined by the perceived presence or absence of requisite resources and 
opportunities and the perceived power of these factors to facilitate or inhibit 
i : ？ 
performance of the behavior (c.f. Conner & Sparks，1996). Though there was no 
1 ‘ 
recent research was found to apply the TPB to study the psychiatric patient's intention 
I I I , 
to take the medication, the TPB has been applied to predict the mother's intention to j 
I 
use oral rehydration therapy for the treatment of the children's diarrhea (Hounsa, et 
al., 1993). Further study of the patients' intention to take lithium by applying the 
TPB may be valuable. 
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Leventhal and colleagues have developed a self-regulatory model (SRM) to 
conceptualize the adherence process (Leventhal, Diefenbach & Leventhal，1992). � 
/ 
According to the model, self regulation is a function of the representation ofheal th 
\ . 
threats and the targets for ongoing coping (e.g. symptom reduction) set by the 
representation, the procedures to regulate these targets, and the appraisal of coping 
outcomes (e.g. whether adhering to the treatment was beneficial). Health-related 
coping responses (e.g. adhering to a treatment) are heavily influenced by one's 
representations of the illness. Leventhal suggested 5 attributes of illness 
representation which included identity (disease label)，time line (health threat is 
acute, cyclic or chronic), causes, consequences, and potential for cure. The attributes 
shape the procedures for coping or controlling and they play an important role in 
appraising the coping outcome. If the patient appraises a particular as ineffective, this 
might result in the selection of an alternative copping strategy or even a change in the 
representation of the illness. Leventhal also emphasizes the importance of conctete 
symptom experience in formulating representations and guiding appraisal o f the 
efficacy of the coping. The dynamic interaction between representations, coping and 
appraisal is guided by person's need to maintain coherence between these processes 
(c.f. Horne, 1997). Leventhal and colleagues (1992) suggested non-adherence was 
common when discrepancies arise between patient and practitioner, and this outcome 
is especially likely for non-western patients in treatment with a western-trained 
psychiatrist, as these patients represent psychiatric disorders as somatic conditions and 
reject psychiatric diagnoses. Oriental patients tended to interpret their symptoms in 
somatic rather than psychological terms, and seek treatments that are physiological 
rather than psychological. Interpersonal inconsistency blocks the formation of a 
coherent system, leaving the patients in an ongoing search for alternative explanations 
for their disorders, resulting eventually in leaving psychiatric treatment. 
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Patient's beliefs about medicines is another important determinant ofpatient 's 
adherence to treatment. Horne and Weinman (1995) developed the Beliefs about 
Medicines Questionnaire (BMQ) to assess beliefs about specific medication � 
i 
prescribed for a particular illness (BMQ-Specific), and beliefs about medicines in 
V. 
general (BMQ-General). The BMQ-Specific contains of two components: Specific-
Necessity and Specific-Concerns. Specific-Necessity represents the beliefs about the 
necessity and efficacy of medicines prescribed for specific condition. The Specific-
Concerns represent the concerns about the harmful effects of medicines prescribed for 
specific condition. The BMQ-General also contains of two components: General-
Overuse and General-Harm. General-Overuse represents the beliefs that medicines in 
general are over-used by doctors. General-Harm represents the beliefs that medicines 
in general are harmful addictive poisons. According to Horne, people seem to 
organize their ideas about medicines (addiction, poison, harm, regular long-term use) 
into coherent themes or component. Although the specific content will vary between 
individuals (e.g. one sees medicines as harmful and addictive, another thinks they are 
generally safe and non-addictive), the components are consistent. 
Horne (1997) investigated the correlation between representations ofillness, 
specific and general beliefs of medication, and self-reported treatment adherence of 
medical patients. Results indicated non-adherence was not associated with the belief 
that medicines were unnecessary or ineffective. The majority ofpatients agreed that 
their present and future health depended on medicines. However, about a third of the 
patients had a complex view of medication iii which beliefs about necessity and 
efficacy were tempered by concerns about the potential harm, and these patients were 
less adherent. The relationship between adherence and patient's concern about the 
potential harm ofmedication (e.g. side-effects) was also found among the patients on 
lithium therapy in western society (Silverstone & Romans, 1996). However, it was 
not an important concern among Chinese psychiatric patients on chronic lithium 
treatment in Hong Kong (Lee, 1993). Thus, it is worth to study the patient's concern 
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about the perceived side-effects as well as the necessity and efficacy ofmedicine 
,. “ 
prescribed. 
“ I � 
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Health Locus of Control 
The relationship ofhealth locus of control and health-related behavior have 
been widely studied. Among the psychiatric population, Kucera-Bozarth, Beck and 
Lyss (1982) studied the relationship between the patients' adherence to lithium 
treatment and their attributions about the contribution of self and other to their ‘ 
psychiatric health. The results indicated that the non-adherent patients were less 
likely to hold an internal Multidimensional Health Locus of Control (MHLC). This 
fmding suggests that people who have a stronger sense of responsibility for their own 
health may have a better adherence. 
Socio-Cultural Factors 
Explanatory Model 
According to Kirmayer, Yong and Robbin (1994)'s review, Arthur Kleinman's 
explanatory model perspective of medical anthropology has directed the attention of 
clinicians to the importance of eliciting culturally distinctive explahatory models of 
patients in order to understand both their illness experience and behavior and their 
response to clinical interventions. Causal attributions or etiological explanations are 
one important aspect of these models. Attributions are cognitive or conceptual links 
between experiences or events and knowledge structures that function as labels, 
categorizations and interpretations of events. Causal attributions indicate whether an 
experience or event is caused by factors within the person, in the situation or context, 
or due to some unique exogenous factor. Kirmayer, Young and Robbins (1994)'s 
review suggests that the explanations tendered and held for symptoms influence 
communication with clinicians, treatment adherence, and the course of illness. 
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Illness Attribution 
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Chinese view of mental illness etiology is multifaceted (Lin & Lin，1981), and 
includes moral, religious or cosmologifcal, physiological, psychological, social and � 
, / 
genetic factors. This multifaceted view was supported by the evidence that psychiatric 
i \ • 
patients seen at psychiatric clinics used both psychological and somatic concepts to 
describe their initial and present problems (Cheung, Lau, & Wong,1984). Luk and 
Bond (1992) examined the perceived importance of causes for ten psychological or 
behavioral problems as evaluated by Hong Kong Chinese. Factor analyses revealed 2 
factors, environmental / hereditary factor and a social-personal factor, from the 26 
causes. The first factor included both internal and external contributors, i.e. 
interactional in nature. Chinese respondents believed that the physical, external 
causes in the environment could lead to internal organic aberrations, with internal 
organic weakness then increasing the susceptibility to these external physical causes. 
The second factor was also interactional in nature. The factor included items that 
were social and psychological in nature, involving the training in morality and 
education the patient received in the past, the social relations of the patients with 
others and certain mental attributes. 
It is not surprising to find that multifaceted view of mental illness etiology 
may lead to different help seeking behavior among Chinese. In the study on Hong 
Kong Chinese psychiatric patients, in addition to seeking help from western medicine 
and mental health service, the reliance on lay resources (traditional medicine and folk 
religion) for a purely psychological problem was also demonstrated (Cheung, 1987). 
More recent study of 100 Chinese psychiatric patients referred consecutively to the 
psychiatric unit of general hospital in Singapore also indicated similar help seeking 
behavior (Kua, Chew, & Ko，1993). In this study, 22% of the patents felt that they 
were possessed by spirits that had caused them to behave and think abnormally. More 
interesting finding is that this cultural belief about spirits and mental illness is not 
related to the educational background, but a higher frequency of women than men 
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believed in possession. Over one third of the patients had consulted a traditional 
•. '•‘ 
healer before coming to the hospital. Psychotic patients (schizophrenia, manic-
depressive psychosis) consulted the traditional healer as often as the neurotic pa t i en t s� 
/ 
(depression, anxiety, and obsession). It is expected that difference in help seeking 
behavior due to the view of mental illness etiology may also be found in drug 
adherence behavior too. 
Though there is no previous study of relationship between the Chinese 
patient's drug adherence and illness attribution, Razali, Khan and Hasanah (1996) 
found that Malay patients who believed in supernatural causes of mental illness were 
observed to show poor drug adherence. The number of patients who ascribed their 
illness to non-supernatural at the 6-month follow-up was significantly higher than the 
number of patients who believed in supernatural causes of their illness. It is expected 
that similar trend can be found in the Chinese population too. 
Attitude Towards Western Medication 
In addition to the view of etiology, Asians' attitude towards western 
medication may affect drug adherence. Lin and Shen (1991) found Southeast Asian 
refugees in western country often had difficulty appreciating the need for maintenance 
therapy in most psychiatric conditions. The lack of immediate therapeutic effects and 
the 2 to 3 week lag time needed for most psychotropics to exert maximal effects were 
incongruent with the preconceptions of the refugee patients toward ‘‘western 
medicine". Moreover, when side effects did occur, these could easily be taken as 
proof that “western medicines" were indeed too strong for them. This finding reflects 
how the lay belief of Asians towards western medicine indeed may influence the drug 
adherence. A commonly held beliefby Chinese and other Asians is that Western 
medicines in general exert their therapeutic effects swiftly ifnot instantaneously, have 
high potential for severe side effects, and are effective only for the control of the 
"superficial" manifestations but not the underlying conditions of diseases (Smith et 
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al., 1993). On the other hand, the Chinese accepted the very bitterness of traditional 
herbal rrtedicine as helpful and good for health. It seems that the culturally ingrained 
health belief may affect the patient's attitude towards the medication and in turn � 
/ 
affects one's acceptance to the treatment. 
� 
Among the Chinese patients who took lithium in Hong Kong, the side effects 
of medication did not associate with non-adherence (Lee, 1993). Lee (1993) studied 
the side effects of chronic lithium therapy in Hong Kong Chinese. Results indicated 
that side effects such as thirsty might perceived by patients as mild “hotness" which 
could be neutralized by “cooling’，effect of water drinking. Lithium was also found to 
be a welcome social stabilizing force. Chinese patients seldom complained of 
"flattened emotions and introversion". Chinese patients seemed to be able to tolerate 
some of the lithium side effects due to traditional health belief and cultural value. 
Somatisation and Social Stigma 
Lin & Lin (1981) suggested that prevailing Chinese approach to mental illness 
was somatisation and denial of psychological involvement. Lin (1982) summarized 
the sociocultural factors that have been proposed to explain this striking characteristic 
feature of somatisation. Firstly, traditional Chinese medical theories and practice, as 
well as folk beliefs strongly influence the perception and concepts of mental disorder. 
Patients who evidence somatisation frequently describe their symptoms in terms of 
dysfunction or imbalance of certain body organs. This mode ofdescription and 
conception of illness is deeply rooted in traditional Chinese medicine which is based 
on the notion of a unitary psychosomatic system. Secondly, somatic symptoms and 
complaints are socially recognized and accepted signals of illness, therefore, play an 
important sick role in the illness behavior of Chinese. Thirdly, there exists a cultural 
taboo on discussing one's emotions directly with others in public. Therefore, the 
psychological or emotional aspects of the patients' morbid conditions are usually 
shielded from surfacing to their own or other's attention. Lastly, somatisation may 
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also be regarded as a reflection of one of the basic cultural traits that permeate the 
Chinese society, consisting of predominance of the oral-hypochondriacal quality. 
• . ‘ 
/ 
The above mentioned prevailing somatisation tendency did relate to the social 
\ 
stigma ofmental illness in Chinese society. Lin & Lin (1981) suggested the shame 
that the family feels about the presence of a mentally ill member is intense and 
pervasive. Therefore, burden on the family seems to be least when it views mental 
illness as medical or physiological in nature and can treat it as such. People may be 
more willing to seek help from the general practitioner but refuse to consult the 
psychiatric servicC. 
Even though the patient are willing to consult the psychiatric service, social 
stigma of mental illness may cause some patients to refuse to take medication in the 
presence of others (Kane, 1985). Stigma associated with the ex-mental patient role 
was found to be specific to that deviant social role (Skinner & Berry，1995). It is 
likely that in traditional China, the burden of the stigma of mental illness tended to fall 
more on the family than the individual (Lin, 1981). Chinese family is so united and so 
concerned with its name that to maintain stability, a member's mental symptoms can 
be denied or tolerated to a dangerous degree O I^g, 1992). According to Lin & Lin 
(1981), the label of mental illness almost instantly and drastically affects the patient 
and alters his status in family. He becomes a mental patient ("crazy") with its 
attendant stigma. The shame and guilt of the family will begin to focus more on the 
patient, along with frustrations, fears and eventual anger. Western study also showed 
that Americans were found to be less authoritarian, less socially restrictive and more 
benevolent towards mentally ill people when compared to Chinese subjects 
(Shokoohi-Yekta & Retish，1991). It is believed that the fear of social stigma may 
cause some patients not seeking treatment or giving up the prescribed medication. 
Similar fear was revealed by Lee et al. (1993)'s study that many Hong Kong patients 
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actually felt ashamed about their mental illness and would like to conceal the 




V . . 
Family support is important for the psychiatric patients especially in the 
Chinese setting because it is an important socialization agent. Kelly and Lambert 
(1992) reviewed that family functioning, especially communication, role pattern, and 
problem solving, has been shown to be an important mediator of adjustment for 
persons with long-term mental illness and substance abuse disorder. Family norms 
and resources influence health behavior. DiMatteo and DiNicola (1982) described 
family support as a link in the intention-behavior chain, enhancing adherence with 
medical treatment, prescribed exercise, diet and fitness programs, home dialysis, use 
of orthotic appliances, and other preventive and rehabilitative regimes. 
According to Kelly & Lambert (1992)'s review, definition of family may 
include companions and close friends as well as those related by blood and marriage. 
Support incorporates the provision of basic social needs (affection, esteem, approval, 
sense of belonging, identity and acceptance, security, sympathy and understanding) 
and socioeconomic or instrumental aids (advice, information, or help with family or 
work responsibilities). To be effective, support received must match the individual's 
perceived need for it. 
Hahlweg and Goldstein (1987) reviewed representative studies concerning 
interaction process in families having a family member with psychiatric disability. 
Findings have evolved into the vulnerability-stress model. It was realized that overly 
sensitive, reactive, emotionally volatile verbal behavior in family members was a 
potent stress factor that interacted with an individual's vulnerability to relapse into 
psychosis. Psychoeducational family intervention was also found as an effective 
‘ i ‘ 
method of improving treatment adherence of patients with schizophrenia and affective 
Drug Adherence 21 
psychoses in rural Chinese community (Xiang, Ran and Li, 1994). It is believed that 
support is also important for the rehabilitation and adherence with medication 
treatment in other forms of mental illness like affective disorder. ‘ 
/ 
� 
For both patients and their families, learning to live with bipolar disorder is a 
difficult process. Silverstone and Romans (1996) suggested that successful 
management ofbipolar disorder required a well informed patient who had a social 
network primed to recognize the early symptoms of an episode and to seek help for 
patients who lack insight into their condition. Family member probably may play an 
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Purposes of the Study 
The present study aimed at examining the individual factors (attitude towards 
the medication, attribution of the mental distress, locus of control and perceived � 
family support) that related to drug adherence of Chinese patients with affective 
V. 
disorder. The dependent variable of present study was the lithium adherence of the 
patients. Adherence was measured by the patient's self report, doctor's report, family 
member's report, as well as the blood lithium level of the patient. It was hypothesized 
that there was discrepancy among all the four measures ofnon-adherence. 
The four major hypotheses of the present study were listed below. 
(1) It was hypothesized that more negative attitudes towards the medication, 
the poorer the adherence would be. Problem attitudes include, opposing to continue 
treatment regiment, not accepting the therapeutic effectiveness of the medication, 
concerning about side effects, difficulty of maintaining pill taking routines, denying 
illness severity, sub-cultural attitude opposed to drug treatment, and dissatisfaction 
with factual knowledge of the medication. 
(2) It was hypothesized that the more a patient attributed his / her mental 
distress to non-western physiological and supernatural causes, the poorer the 
adherence would be. 
(3) It was hypothesized that the patients who tended to have a chance Iocus of 
control (i.e. those who consider that the health condition is due to chance), or less 
internal locus of control, would have poor adherence. 
(4) It was hypothesized that family support (emotional and instrumental), 
> 
would be positively related to adherence. 








Sixty-three adult Chinese patients on maintenance lithium treatment at the Li 
Ka Shing Psychiatric Clinic of Prince ofWales Hospital were invit6d to participate in 
this study. One patient refused to give the consent for the participation. Two cases 
were discarded because they were not on lithium treatment after checking the lab 
results. According to Goodwin and Jamison's (1990) review of past studies about 
correlates of lithium adherence, the sample size was ranged between 26 to 133. 
Considering the previous local study by Lee (1993), the sample size was 50. Thus, the 
sample size of the present study was determined to be not less than 50. Among the 60 
successfully interviewed patients, there were 21 males (35%) and 39 females (65%) 
with a mean age of38.02 years (SD =10.83 years, range 22-69 years). The mean age 
of male patients were 35.1 years (SD=10.2 years) and the mean age of female patients 
were 39.6 years (SD=10.9 years). There was no significant difference in age between 
males and females, t (58)=-1 .55 ,� . 13 . There were 16 patients (26.7%) within the age 
ranges of21-30, 26 patients (43.3%) within the age range of31-40, 11 patients 
(18.3%) within the age range of 41-50, 3 patients (5%) within the age range of51-60, 
and 4 patients (6.7%) within the age range of 61-70. Thirty-two (53.3% ) patients 
were married, 23 (38.3%) were single and 5 (8.3%) were divorced. 33 (55%) patients 
were employed (full time/part-time employment), 10 (16.7%) were 
unemployed/retired and 17 (28.3%) were housewife. For education level, 10 (16.7% ) 
patients were primary school educated or below, 15 (25%) werejunior high school 
educated, 25 (41.7%) were high school educated and 9 (15%) were tertiary educated. 
According to the self-report of medication history, patients had been 
continuously taking lithium an average of 6.2 years (SD=3.52, range=l-17). 16 
patients (26.7%) were on lithium only. The mean number of medication they were 
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taking was 2.38 (SD=1.15, range=l-5). The diagnoses were obtained by the case 
psychiatrist through case note review. Patients' diagnoses were as follows: manic 
depressive disorder (bipolar) (90%), unipolar major depression (8.3%) and � 
schizoaffective disorder (1.7%) (APA, DSM-IV). All patients were in clinical 
V. 
remission at the time of the study. They all gave written consent for their participation 
in the study. 
Outcome Measures 
Blood level monitoring 
The mean of the last two serum lithium levels recorded for each patient was 
used as an indicator of adherence. As in a previous study (Lee, 1993)，mean lithium 
level ofless than 0.45mmol/litre was one of the criteria indicating non-adherence. 
Patient self report, family member 's report, and case doctor ’s report 
Patients, family members and psychiatrist were asked by questionnaire to 
determine the drug treatment adherence of the patient in the past 1 year. To replicate 
the study of Gitlin, et al.(1989) with some change, patients were asked to rate 
themselves on a 4-point scale that described current compliance, ranging from 1 "have 
stopped taking the medication completely" to 4 “am taking the exact dosage every 
day，，. Patients and family members were also asked if the patient had ever not 
following the prescription. Family members of the patients were interviewed by 
telephone. Again, consent were obtained from the patients. 46 (76.7%) family 
� 
members were successfully interviewed by phone. 
Pill count method was not chosen in the present study because electronic pill-
count monitoring was not available in Hong Kong. Moreover, the patients were on 
chronic lithium treatment of average 6 years. Some of the patients were followed up 
by the psychiatrist every six months. Such a long follow-up time might not be 
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suitable for using pill count method because they were prescribed for a large amount 
of medication. 
“ I � 
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Non-adherence was regarded as present when any one or more o f t h e 
s . 
following four criteria was met: 1) mean lithium level < .45 mmol/l; 2) psychiatrist's 
report of non-adherence, i.e. ‘3，(sometimes taking less than prescribed) or ‘2，(most 
of the time not taking the medication) or ‘ 1，(have stopped taking the medication 
completely); 3) patient's self-report of non-adherence (same criteria as psychiatrist's 
report); and 4) family member's report of non-adherence (same criteria as 
psychiatrist's report). 
Full-adherence was defined as a consensus across the above measures that the 
patient was adhering to the regimen. 
Side Effect Measure 
Side Effecl Checklist 
A side effect checklist which was based on the past study ofLee (1993) was 
used to check whether the patient had experienced the side effect or not. The 
checklist contained 34 side effects. The patientsjudged their recent experience of 
side-effect on a 4 point scale (rating from 0 to 3). The intensity of each side effect 
was scored as ‘0’ (nil), ‘1，(mild), ‘2，(moderate), ‘3，(severe) respectively. 
Attitude Measures 
.Lithium Attitudes Questionnaire - LAQ (Harvey, 1991) 
The lithium attitude questionnaire was developed as a means of identifying 
and grouping the problems patients commonly have with taking lithium regularly. It 
was a 19-item questionnaire. The patients only needed to respond in "yes" or “no’，. 
The items were designated to seven attitude sub-categories: (l)opposed to continuing 
lithium treatment regimen; (2) therapeutic effectiveness oflithium not accepted; (3) 
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concerned about side-effects; (4) difficulty maintaining, pill-taking routines; (5) denial 
« 
ofillness severity impairing lithium prophylaxis; (6) sub-cultural attitude opposed to 
drug treatment; and (7) dissatisfaction with factual knowledge of lithium). Harvey � 
(1991) reported that the test-retest reliability of the nineteen items (Cohen's K) was 
V. 
ranged between 0.0 to 0.9. Most of the K values showed good observed probability of 
agreement. The four items with a K equal to 0 had a very high percentage agreement 
(78% to 96.6%). Ill this situation the zero K does not indicate low agreement but 
suggests that the particular group of patients in the study were unresponsive to these 
items. 
Mental Distress Explanatory Model Questionnaire - MDEQ 
(Eisenbruch, 1990) 
The original Mental Distress Explanatory Model Questionnaire was a 45-item 
questionnaire designed to explore how people from different cultures explain mental 
distress. Four clusters of mental distress were as follows : (1) stress; (2) western 
physiological; (3) non-western physiological; (4) supernatural. The questionnaire has 
the potential to be used for anticipating the patients' as well as families' beliefsystem 
that might support or oppose treatment. 
The version used by the present study consisted of 16 items. The items chosen 
were determined by a pilot study. 101 undergraduate students (48 males and 53 
females of mean age 19.9 years, SD 1.2) completed the MDEQ. The internal 
consistency (Cronbach Alphas) of the four mental stress scales , i.e. Stress; Western 
Physiological; Non-western Physiological; and Supernatural were computed. The 
alpha for Stress = .85, for Western Physiological 二 .76，for Non-western Physiological 
=.57, and for Supernatural = .86. Those items ofhighest corrected item-total 
correlation were chosen for the short-version. The corrected item-total correlation 
were as follows: (1) Stress (ranging from .58 to .63); (2) Western Physiological 
(ranging from .47 to .55); (3) Non-western Physiological (ranging from .20 to .49); 
and (4) Supernatural (ranging from 58 to .73). The patientsjudged how likely it was 
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that each of listed causes could contribute to mental distress and to respond on a 5-
t 
point Likert scale ranging from “not at all likely” to “highly likely". 
‘ I ^ 
‘ i 
Multidimensional Health Locus of Control Scales Form A - MHLC-A 
\ 
(Wallston, Wallston, & Dvellis，1978) 
The MHLC scales was a health belief measure that assessed individuals' 
attribution about influences on their health and illness and had been used widely in 
studies ofhealth-related behavior. The Form A was an 18-item questionnaire. The 
MHLC provided 3 dimensions for health belief measurement: internal health locus of 
control (II ILC)，powerful others-external health locus of control (PHLC) and chance-
external health locus of control (CHLC). Internal consistency analyses indicated that 
Cronbach alpha for IHLC=0.61-0.80, CHLC=0.55-0.83 and PHLC=0.56-0.75 
(Wallston, Wallston, & Dvellis，1978). Patients were asked to respond on a 5-point 
Likert scale from “strongly agree" to “strongly disagree". 
Support Measure 
Social Support Questionnaire (Wills, 1985) 
It was a 15-item questionnaire. Patients were asked to respond on a 5-point 
Likert scale from "strongly agree" to "strongly disagree". Perceived instrumental 
support and emotional support from the family were assessed in this questionnaire. 
Final scales were constructed with equal-weighted scores based on internal 
consistency analyses indicating Cronbach alpha == .81 for a seven-item emotional 
support scale and alpha = .74 for an eight-item instrumental support scale (Wills, 
Vaccaro, & McNamara, 1992). 
Mood State Measure 
Beck Depression Inventory Short Form (Beck & Beck，1972) 
The Beck Depression Inventory Short Form was an abbreviated version of a 
21 -item self-report screening test for depression. Thel3-item short form BDI tapped 
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symptoms of sadness, pessimism, failure as a person, general dissatisfaction, guilt, 
self-dislike, suicidal ideation, social withdrawal, indecisiveness, poor self-image, 
work inhibition，fatigue, and lack appetite or anorexia. Patients required to respond ^ 
on a 4-point, fixed-response scale. Total score derived from a sum of the item scores. 
V. 
Memory Function Measure 
Daily Memory Functioning Questionnaire 
Four items adopted from an unpublished questionnaire of the Hospital of San 
Diego were used to measure the patients' memory functioning in daily life. It was a 4-
item questionnaire. Patients were asked to respond on a 7-point Likert scale from 
'0'(almost none) to ‘6’ (almost always). 
Procedure 
The questionnaire interview was carried out at the outpatient psychiatric clinic 
of a large regional hospital in Hong Kong from September 1997 to February 1998. All 
the participants of present study were identified at the clinic through convenient 
sampling irrespective of their adherence status. They were interviewed by the 
researcher using the structured interview questionnaire. Follow up telephone 
interview of the patient's family member was done to obtain the indirect measure of 
adherence. The case psychiatrist was invited to rate the patients’ adherence level by a 
brief questionnaire. The researcher checked the last two lithium level records for each 
patient from the database of the hospital. 







Thirteen (22%) patients had mean lithium level <.45mmol/l. The non-
adherence rate of self-report, case psychiatrist's report, and family member's report 
were 57%, 53%, and 37% respectively. The number and percentage of different 
measures of adherence are presented in Table 1. 
Table 1 














Stop completely, N(%) ~ ~ ~ ^ ) ~ ~ ^ ) ~ ~ ~ - -
Most of the time not 
taking, N(%) 
2(3.3) 10(16.7) - -
Sometimes taking less 
than prescribed/ not 
taking, N(o/o) 
31(51.7) 21(35) 17(37) -
Follow the exact dosage 
everyday，N(%)  
26(43.3) 28(46.7) 29(63) -
Mean lithiuni level 
< 0.45mmol/litre, N(%) 
- - - 13(21.6) 
By multiple criteria (i.e. non-adherence was regarded as when any one or more 
of the above criteria was met), 44 (73%) patients were non-adherent and 16 (27%) 
were fully adherent. 11 of them met 1，15 met 2, and 17 met 3 and 1 met all the 4 
criteria for non-adherence. 
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Intercorrelations of Adherence Measures 
I I 
• 
Non-parametric intercorrelation of the adherence measures are reported in 
Table 2. The self-report showed a sigriificant positive correlation with all three o t h e r � 
/ 
measures (case psychiatrist's report r=.42, ^<.01; family's report r=.36, n<.05; blood 
V. 
level monitoring r=.41, g<.01). Case psychiatrist's report also showed significant 
positive correlation with blood level monitoring (r=.32, E<.05). However, the family 
i 
member's report did not have significant correlation with case psychiatrist's report 
and blood level monitoring. 
Table 2 
Spearman Nonparametric Intercorrelations of Adherence Measures 







Psychiatrist's report 60 .42** -
Family member's report 46 .36* .23 -
Blood level monitoring 60 .41** .32* m  
Note. * e<.05 
** 2 < . 0 1 
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Mean Lithium Level and Adherence Status 
:. •* 
4 
The mean lithium level of each patient and his/her adherence status are 
presented in Table 3. The mean lithium level of the 60 patients was 0.59 mmol/litre 
f 
(SD=0.17 mmol/litre, range=0.20 to 0.90 mmol/litre). Among the 13 patients with 
mean lithium level was below 0.45mmol/litre, 1 patient reported that she "followed 
the exact dosage everyday" and 10 of them reported "sometimes taking less than 
prescribed". One patient reported that he “stopped the medication completely" and 
one reported that he was “not taking the medication for most of the time". 
Among the 13 patients with mean lithium level below 0.45 mmol/litre, 8 
family members were successfully interviewed. Five of themjudged the patients as 
“following the exact dosage everyday" and 3 of themjudged the patients as 
"sometimes taking less than prescribed". 
Among the 13 patients with mean lithium level below 0.45 mmol/litre, case 
psychiatristjudged 4 of the patients as ‘‘following the exact dosage everyday", 2 of 
them as “sometimes taking less than prescribed", 6 of them as “most of the time not 
taking", and 1 as "stopping the medication completely”. 
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I ^ w l i m e s laking Icss lhan prcscribcd/not taking; 4 = follow the exact dosage everyday 
Bolded cases • = mean lithiiim level < 0.45 mmol/lilre 
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The Reliability of the Instruments 
i . .“ 
The reliability of various instruments used in the present study were computed 
and listed below. The internal consistency reliability of the Lithium Attitude � 
/ 
Questionnaire (LAQ) was 0.62. 
The internal consistency reliabilities of the four subscales of the Mental 
Distress Explanatory Model Questionnaire (MDEQ), i.e. Stress, Western 
Physiological, Non-western Physiological, and Supernatural were listed below. The 
alpha for Stress was 0.73, for Western Physiological was 0.60，for Non-western 
Physiological was 0.77，and for Supernatural was 0.77 respectively. 
The internal consistency reliabilities of the three subscales o f the 
Multidimensional Health Locus of Control Scales - Form A (MHLC-A), i.e. IHLC, 
PHLC, CHLC were 0.65, 0.49, and 0.68 respectively. 
The internal consistency reliabilities of the two subscales of the Social 
Support Questionnaire, i.e. Instrumental Support and Emotional Support were 0.86 
and 0.88 respectively. 
The internal consistency reliability of the Beck Depression Inventory 
(BDI)questionnaire was 0.82. 
The internal consistency reliability of the Memory Functioning Questionnaire 
was 0.75. 
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Comparison ofFully Adherent and Non-adherent Patient , 
Comparison between fully adherent patients and non-adherent patients on 
demographic variables, illness and medication variables, mood state, memory � 
/ 
function, attitude variables are reported in Table 4，5 and 6 respectively. 
� . . . 
Among the demographic variables, only the employment status distinguished 
between fully adherent and non-adherent patients,X^(2, N=60)=7.08, j3<.05. Further 
comparison indicated that housewives tended to be non-adherent,X^(l,N=17)=7.12, 
g<.05. The unemployed patients were also more likely to be non-adherent, as all the 
10 unemployed patients belonged to the non-adherent group. However, there was no 
2 
significant cliffcrcnce in the employed group,X (l,N=33)=1.48, ]3>.05). 
Among the illness and medication variables, the non-adherent patients' 
duration of taking lithium (M=6.67 years, SD=3.74) reported to be significantly longer 
than the fully adherent patients (M=4.68, gD=2.31), t(58)=2.09, 2<-05. Consistent 
with expectation, the fully adherent and non-adherent patient groups did not differ 
significantly on the mood state measure and daily memory functioning. However, 
sex, age, marilal status, education level, living alone, number of medication currently 
taking did not differ between two groups of patients (See Table 4 & 5). 
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Table 4  _ •-" 
Demographic, Illness Variables ofPatients. According to the Pattern ofAdherence 
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Living alone, N(%) 2(12.5) 2(4.5) 1.19 .27 
Diagnoses 
Bipolar Disorder, N(%) 
Depression, N(%) 







Mood state measure 
BDI > 8 






Memory functioning measure 
Daily memory functioning (mean 士 SD) 0.71土0.74 0.84 土0.93 0.48 .64 
Note. BDI=Beck Depression Inventory 
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Table 10 
Medication Variable and Side Effect Measure ofPatients, According to the Pattern of 
Adherence with Lithium 
T ^ 
/ 















2.24 1 3 
Number of medication 
(mean 土 SD) 
Duration of taking lithium 
(mean 土 SD y) 
2.69±1.08 2.27土1.17 
4 . 6 8 ± 2 . 3 1 6 . 7 6 ± 3 . 7 4 
1.24 .22 
2.09 .04* 
Side effect score (mean 土 SD ) 1 2 . 3 8土 1 1 . 2 0 1 6 . 4 8土 1 3 . 2 4 10 .28 
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On the attitude measures, the non-adherent patients scored higher on the LAQ 
(i.e. greater number of negative attitude reported) (M=6.05, SD=2.91) than the fully 
adherent patients (M=4.06, SD=2.46),t(58)=2.43, p<.05. Among the seven attitudes,� 
/ 
two attitude sub-categories found to have significant difference. The non-adherent 
V 
patients (M=1.34, SD=0.86) scored higher than the fully adherent patients (M=0.75, 
SD=0.68) on the attitude of opposing to continue lithium regime, t(58)=2.47, 2<.05. 
The non-adherent patients (M=1.14, SD=0.73) also scored higher on the denial of 
illness severity than the fully adherent patients (M=0.56,SD=0.81), t(58)=2.60, n<.05. • � 
However, other attitude sub-categories did not differ significantly between the two 
groups. There was also no significant difference between the non-adherent and fully 
adherent patient group on the MDEQ, MHLC and social support measures (See Table 
6). 
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Table 6 
Attitudes and Perc~ived Support of Patients, According to the Pattern of Adherence 
With Lithium 
'. Fully Non 
Adherent -adherent t-
Variables (N=16) (N=44) value 
LAQ (mean ± SD ) 
LAQ Score 4.06±2.46 6.05±2.91 . 2.43 .02* 
Opposed to continue Li treatment regimen O.75±0.68 1.34±O.86 2.47 .02* 
Therapeutic effectiveness of Li not accepted 0.19±0.40 0.30±0.55 0.71 .48 
Concerned about side effect 0.56±O.51 0.75±O.75 0.92 .36 
Difficulty of maintaining pill taking routine 0.56±0.96 0.89±0.92 1.19 .24 
Dcniul of illness severity O.56±0.81 1.14±O.73 2.60 .01 * 
Sub-cultural altitudes opposed to drug treatment 0.88±1.03 1.11±0.92 0.86 .39 
Dissatisfaction with factual knowledge of Li 0.56±0.51 0.52±0.51 -0.27 .79 
MDEQ 
Stress 2.89±1.18 3.48±.1.05 1.88 .07 
Western physiology 2.59±1.10 2.96±0.98 1.24 .22 
Non-western physiology 1.92±O.96 2.35±1.20 1.29 .20 
Supernatural 1.73±0.98 2.l9±1.13 1.44 .16 
MI-ILC 
Internal LOC 3.56±0.80 3.39±0.87 -0.68 .50 
Powerful others LOC 
. 3.80±0.74 3.63±0.72 -0.80 .43 
Chance LOC 2.19±0.91 2.34±0.85 .62 .54 
Social Support 
Emotional support 3.96±1.00 3.80±1.00 · -0.54 .59 
Instrumental support 3.37±1.13 3.54±l.O3 0.57 .57 
Note. LAQ = Lithiulll Attitude Questionnaire 
MDEQ = Mental Distress Explanatory Model Questionnaire 
MI-ILC = Multidin1ensional I-Iealth Locus of Control 
*Q<.05 
** ..Q<.01 
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Discriminant Analysis 
A two-group discriminant analysis was performed to see whether the fully 
adherent and non-adherent group could be differentiated by the demographic, clinical，' 
！ 
attitude and support variables. A stepwise method which minimized the Wilks' 
V. 
lambda with an inclusiony'exclusion criterion of FD^=3.84/FOUT=2.71 was used to 
identify the two groups. Based on the standardized canonical discriminant 
coefficients of predictor variables, age of21-30, the denial of illness severity, mono-
pharmacy, and being employed were found to be important predictors. The 
coefficients for the function were .62，.58, .74，and -.90. The correct classification 
rate was 78.33%. The Wilks' lambda for this analysis was .65 (X^=23.83, df=4, 
e<.001), showing that the means of the function were significantly different in twd 
groups. 
Drug Adherence 40 
Comparison of the Patients’ Attitudes and Social Support bv the Number ofNon-
adherence Criteria Met ' 
1 » 
/ 
A non-adherence criteria score was computed by counting the number of non-
adherence criteria met by the patients. The score range from 0 (no non-adherence 
criteria was met) to 3 (three or more non-compliant criteria were met). The frequency 
of non-adherence composite score is listed in Table 7. 
Table 7 
Frequency ofNon-adherence Criteria Score 
Number of Patient 
Non-adherence Composite Score  N(o/o)  
0 — 16(26.7) ‘ 
1 11(18.3) 
2 15(25.0) 
3  18(30.0) 
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Analysis ofVariance results indicated there was difference in attitudes toward 
the lithium treatment, illness attribution,'and support measures, according to the non-
adherence criteria score, i.e. the number of non-criteria met. The ANOVA results were 
listed in the Table 8. 
� 
On the attitude towards the lithium treatment, there was significant difference 
on the LAQ score by the non-adherence criteria score (F(3,59) = 3.09，g<.05). Post-
hoc analysis (Tukey-HSD Test with significance level at .05) indicated that those 
I 
patients who met 3 or more non-adherence criteria scored higher on the LAQ 
(M=6.94, SD=2.86 ) than those who were fully adherent group (M=4.06, SD=2.46). 
Among the 7 attitude sub-categories, there was significant difference on the attitude 
towards the therapeutic effectiveness (F(3,59) = 3.05, g<.05). However, post-hoc 
analysis failed to indicate any group had significant difference. 
On the MDEQ, there was a significant difference on the attribution of stress as 
the cause of mental distress by the non-adherence criteria score (F(3,59) = 3.99， 
p<05). Post-hoc analysis indicated that only those patients who met 3 or more non-
adherence criteria (M=3.71, SD=0.86) scored higher on the attributing stress as the 
cause of mental distress than the fully adherent group (M=2.89, SD=1.18). 
On the social support measure, there were significant difference on both 
emotional and instrumental support by the non-adherence criteria score (F(3,59)= 
3.34 and F(3,59) = 2.94, g<.05). Post-hoc analysis indicated that those patients met 
only 1 non-adherence criteria scored (M=4.56, SD=0.53) higher on emotional support 
than those who met 3 or more non-adherence criteria (M=3.50, SD=0.97). Those who 
met 1 non-adherence criteria (M=4.30, SD=0.76)scored higher on instrumental 
support than those who met 2 non-adherence criteria (M=3.21, SD=1.12). However, 
there was no significant difference on the health locus of control. 
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Table 10 
One-way ANOVA Of the Attitude Variables and Support Measures bv the Non-




Opposed 10 continue Li trcatmcnl regimen 
Therapeutic elTectiveness o f L i nol accepted 
Concerned about side effect 
Difficiilly of maintaining pill taking routine 
Denial ofillness severity 
Sub-cultural altitudes opposed to drug treatment 











F(3,59) = 2.59 
F(3,59) = 0.60 






F(3,59) = 3.99* 
F(3,59) = 2.16 




Powerful olhcrs L O C 
C h a n c c L O C 
F(3,59) = 0.32 
F(3,59) = 0.96 




F(3,59) = 3.34* 
F(3,59) = 2.94* 
Note. LAQ = Lithium Attitude Questionnaire 
MDEQ = Mental Distress Explanatory Model Questionnaire 
MHLC = Multidimensional Health Locus of Control 
n<.05 
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Comparison ofPatients’ Attitudes and Perceived Support bv Patient's Self-report of 
f . '• 
» 
Adherence 
The results listed in Table 9 are the comparison of patients' attitudes and � 
perceived support by the self-report of adherence. On the Lithium attitude measures, 
the patients whojudged themselves as non-adherent (sometimes taking less than 
prescribed “3” to stop the medication completely “1，，) scored higher on the LAQ 
(M=6.35, SD=3.05) than patients whojudged themselves as fully adherent (follow the 
exact dosage everyday “4”）(M=4.42, SD=2.35), t(58)=2.67, ^<.05. Among the seven 
attitudes，two altitude sub-categories found to have significant difference. The 
patients whojudged themselves as non-adherent (M=1.47, SD=0.86) scored higher 
than thosejudged themselves as fully adherent (M=Q.8K SD=0.69) on the attitude of 
opposing to continue the lithium regimen, t(58)=3.21,p<.01. The non-adherent 
patients (M=1.18, SD=0.72) also scored higher on the denial of illness severity than 
the fully adherent patients (M=0.73, SD=0.83), t(58)=2.23, e<.05. However, other 
attitude sub-categories did not differ significantly between the two groups. There was 
also no significant difference between the non-adherent and fully adherent groups on 
the MDEQ, MHLC and social support measures (See Table 9). 
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Table 10 
'Attitudes and Perceived Support of Patients, According to the Pattern ofAdherence 
with Lithium by the Patient's Self-Report 
Self-Report 
F ^ Non 
Adherent -adherent t- n 
Variables  0 ^ = 2 6 ) QSK34) value 
L A Q ( m e a n ± S D ) 
LAQ Score 4.42±2.35 6.35土3.05 2.67 .01* 
Opposed to continue Li lrcatmcnt regimen 0.81±0.69 1.4710.86 3.21 .002** 
Therapeutic effecliveness o f L i not accepted 0.15i0.37 0.35i0.60 1.59 .12 
Concerned aboul side effect 0.5810.58 0.7910.77 1.20 .23 
Dinicul ly ut' maintaining pill laking routine 0.58±0.86 0.97±0.97 1.64 .12 
Denial of illness severity 0.7310.83 1.18±0.72 2.23 .03* 
Sub-cultural attitudes opposed to drug treatment 1.00土1.02 1.0910.90 0.36 .72 
Dissatisfaction with factual knowledge o f L i 0.57+0.50 0.50±0.51 -0.58 .56 
MDEQ 
Stress 3.01土1.16 3.57i l .01 1.99 .05 
Western physiology 2.73土1.03 2.96土1.00 0.88 .38 
Non-western physiology 2.13士1.08 2.32土1.22 0.60 •55 
Supernalural 1.88士1.09 2.22土1.11 1.21 .29 
MHLC 
• 
IiUcrnul L O C 3.56土0.78 3.34土0.90 -1.00 .32 
Powerful olhcrs L O C 3.77土0.73 3.61土0.73 -0.85 .40 
Chance U ) C 2.36+0.86 2.26±0.87 -0.44 .66 
Social Support 
Emotional support 4.08±0.91 3.66土1.03 -1.64 .11 
Instrumental support 3.54±1.11 3.46土1.02 -0.30 •76 
Note. LAQ 二 Lithium Attitude Questionnaire 
MDEQ = Mental Distress Explanatory Model Questionnaire 
MHLC = Multidimensional Health Locus of Control 
*e<.05 
**_p<.01 
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Comparison of Patients' Attitudes and Perceived Support bv Family Member's Report 
‘ . •• 
of Adherence ,. 
• » 
The results listed in the Table 10 are the comparison of patients' attitudes and ‘ 
/ 
perceived support by the family member's report of adherence. On the 
\ 
Multidimensional Health Locus of Control (MHLC), those patients who judged by the 
family member as fully adherent (M=3.97, SD=0.62) scored higher on the powerful 
others locus control than those whojudged by family member as non-adherent 
(M=3.27, SD=0.79), t(44)= -3.30, e<.01. 
Among the social support measures, those patientsjudged by family member 
as fully adherent scored higher on both emotional (M=4.25, SD=0.77) and 
instrumental (M=3.87, SD=0.96) support than those whojudged by family member as 
non-adherent (M=3.40, SD=0.93; M=3.15, SD=0.87), (t(44)=-3.31,n<.01;i(44)=-
2.54, e<.05). 
However, the LAQ and MDEQ did not differ significantly between the two 
groups (See Table 10). 
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Table 10 
Attitudes and Perceived Support ofPatients, According to the Pattern of Adherence 
with Lithium by the Family Member's Report 
Family Member's Report 
F ^ Non 
Adherent -adherent t- n 
Variables  qs[=29) Gs[=17) value 
LAQ (mean 士 SD ) 
LAQ Score 5.24±3.14 6.00±2.69 0.83 .41 
Opposed to continue U treatment regimen 1.14±0.79 1.29±0.92 0.61 .54 
Thcrapcutic elTecliveness of L i not accepted 0.28土0.53 0.47土0.62 1.13 .27 
Concerned about side effect 0.72土0.70 0.76±0.75 0.18 .86 
Dirficully ofmaintaining pill taking routine 0.70土1.00 0.76±0.75 0.27 .79 
Denial ofillness severity 0.90±0.86 1.00±0.71 0.42 .68 
Sub-cultural attitudes opposed to drug treatment 0.90土1.05 1.18±0.73 0.97 .34 
Dissalisfaction vvilh factual knowledge o f L i 0.62土0.49 0.53土0.51 -0.60 .55 
MDEQ 
Stress 3.26土1.18 3.47±1.08 0.60 .55 
Western physiology 2.89±1.13 2.65±0.83 -0.77 .45 
Non-weslcrn physiology 2.41±1.23 2.40±1.19 -0.02 .98 
Supernatural 2.00±1.11 2.37土1.26 1.03 .31 
MHLC 
lnicmal L O C 3.55+0.82 3.25±0.78 -1.25 .22 
Powerful olhers L O C 3.97士0.62 3.27±0.79 -3.30 .002** 
Chance L O C 2.61i0.95 2.17士0.75 -1.66 .10 
Social Support 
Emolional siipporl 4.25土0.77 3.40i0.93 -3.31 .002** 
lnstruinenlal supporl 3.87土0.96 3.15±0.87 -2.54 .015* 
Note. LAQ = Lithium Attitude Questionnaire 
MDEQ == Mental Distress Explanatory Model Questionnaire 
MHLC = Multidimensional Health Locus of Control 
*e<.05 
**_e<.o i 
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Comparison ofPatients，Attitudes and Perceived Support bv Case Psychiatrist's 
Report of Adherence 
The results listed in the Table 11 are the comparison of patients，attitudes a n d � 
perceived support by the case psychiatrist's report of adherence. On the Lithium 
� . . 
Attitude Questionnaire (LAQ), the patients whojudged by case psychiatrist as non-
adherent scored higher on the LAQ (M=6.22, SD=2.99) than patients who judged by 
case psychiatrist as fully adherent (M=4.71, SD=2.65), t(58)=2.05, p<.05. However， 
the altitude sub-categories did not differ significantly between the two groups. There 
was also no significant difference between the non-adherent and fully adherent groups 
on the MDEQ, MHLC and social support measures (See Table 11). 
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Table 11 
Attitudes and Perceived Support of Pati~I?ts, According to the Pattern of Adherence 
with Lithium by the Case Psychiatri.st's Report 




Variables (N=28) (N=32) value 
LAQ (nlean ± SD ) 
LAQ Score 4.71±2.65 6.22±2.99 2.05 .045* 
Opposcd to continuc Li ~rcatlllcnt regimen 1.00±0.77 1.34±0.90 1.58 .12 
Therapeutic effcctivenes's of Li not accepted 0.18±0.39 O.34±0.60 1.28 .21 
Concerned about side effect 0.57±0.57 0.81±0.78 1.35 .18 
Dilliculty of maintaininr pill taking routine O.71±0.98 O.88±0.91 0.66 .51 
Denial of illness severity 0.79±0.83 l.l6±0.72 1.85 .07 
Sub-cultural attitudes opposed to drug treatment 0.93±0.94 1.16±0.95 0.93 .36 
Dissatisfaction with t1lclual knowledge of Li 0.54±0.51 0.53±0.51 -0.03 .97 
MDEQ 
Stress 3.23±1.14 3.41±1.08 0.61 .54 
Western physiology 2.83±1.05 2.89±0.99 0.23 .82 
Non-western physiology 2.15± 1.14 2.31±1.17 0.54 .59 
Supermltuml 1.98±1.16 2.15±1.06 0.58 .56 
MHLC 
Intermll Loe 
- 3.38±0.86 3.49±O.85 0.49 .63 
Powerful others LOe 3.70±0.65 3.66±0.80 -0.24 .81 
Chance LOe 2.33±0.93 2.28±0.81 -0.21 .84 
Social Support 
Emotional support 3.94±1.04 3~75±0.96 -0.71 .48 
Instrumental support 3.49±1.10 3.50±1.02 0.06 .95 
Note. LAQ = Lithiunl Attitude Questionnaire 
MDEQ = Mental Distress Explanatory Model Questionnaire 
MI-ILC = Multidimensional I-Iealth Locus of Control 
*Q<.05 
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Chapter 4 
_. •  
Discussion 
Single vs. Multiple Criteria • ^ 
/ 
The self-reported non-adherence rate (57%) was highest among the 4 
V * 
adherence measures including psychiatrist's report (53%), family member's report 
(37%), and blood level monitoring (22%). It is suggested that a non-prescribing 
interviewer might be more able to elicit self-reported non-adherence than the 
paternalistic prescribing doctor (Lee, 1993). The lowest non-adherence rate was the 
blood level monitoring (22%). It should be noted the blood plasma concentration 
reflects the previous week or more, non-adherent patients who only take the 
medication before the week of blood test may not be detected by the blood test. It was 
not uncommon as previous studies using routine lithium levels to measure adherence 
did not fmd higher rates of non-adherence than studies relying on patient self-report 
(Cochran, 1986). Moreover, the current subjective report of non-adherence was on a 
four-point scale from “follow the exact dosage everyday，，to “stop the medication 
completely". Those patients who reported "sometimes taking less than prescribed” 
might not be detected by the blood test. Another interesting finding is that the family 
member's report of non-adherence (37%) is lower than the self report (57%) and 
psychiatrist's report (53%). The lower non-adherence rate of family member's report 
in comparing to lhe other two adherence measures (self report and psychiatrist's 
report) may be related to the fact that some patients refused to designate an informant. 
Thus, the family's report might probably be an underestimation of the actual non-
adherence. 
Consistent with expectation, there was moderate positive correlation among 
the self-report, doctor's report and blood level monitoring. However, the family 
member's report of adherence failed to have significant correlation with the 
psychiatrist and blood level monitoring. Family member's report was hampered by 
.* 
the fact that only 46 patients could or would designate an informant. Moreover, tllis 
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method is also dependent on the relative's willingness to report non-adherence (Evans 
. . V. 
» 
& Spelman，1983). Follow-up interviev/ of family member also indicated that some 
family members actually did not take care of the patients' medication regimen. � 
/ 
Among the 46 family members interviewed, nine (19.6%) of them reported that they 
V • 
did not know the number of medication that the patients were currently taking. 
Patients may also refuse to let others know about their psychiatric medication, as 
mental illness is still a stigma in the Hong Kong society. It seems that the family 
member's report is the least reliable one. 
For the present study, multiple criteria was chosen instead of single criterion in 
detecting non-adherence because there was discrepancy among different measures of 
non-adherence. Depending on single criterion may lead to underestimation. For 
instance, if only the blood level monitoring was used, the non-adherence rate might 
only be 22%. By the multiple criteria, non-adherence rate (73%) of the present study 
was much higher than expected. Such a high non-adherence rate indicates it is a 
normal phenomenon for patients who are on chronic medication treatment to be 
sometimes taking less medication than prescribed. Clinically, they might not be the 
group that required intervention in medication adherence. By altering the non-
adherence criteria to “most of time not taking the medication", the hon-adherence rate 
might drop sharply. The non-adherence rate of self-report and psychiatrist's report are 
5% and 18% respectively. As mentioned before, difference in prevalence rate of non-
adherence may partly be due to the differences among these studies in the definition, 




Lee's research (1993) found that the non-adherence rate was 30% among the 
patients on chronic lithium in Hong Kong. The past researches indicated that the 
estimate of lithium patients' non-adherence rate was ranged from 12 to 66% (Cochran 
and Gitlin, 1988; Keck, et al.l997). It is first speculated that the present higher 
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adherence rate might partly be related to the more non-adherence measures being used 
* 
in the present study. Instead of three adherence measures (self-report, psychiatrist's 
report, blood level monitoring), family'member's report was added. However, w h e n � 
i 
excluding the family member's report, the non-adherence rate only has a small amount 
V 
of reduction to 71.7%. This might probably be related to the relatively low non-
adherence rate reported by the family member (37%). Second speculation is that 
current report of adherence used a four-point scale from "follow the exact dosage 
everyday” to “stop the medication completely", the respondent might find it was less 
threatening to report that they were sometimes taking less than prescribed/not taking. 
Thus, they might be more willing to report non-adherence. 
To sum up, the family member's report appeared to be the least reliable one in 
measuring medication adherence. The four-point measure of adherence allowed us to 
judge the patients' adherence in a continuum. The patients who were clinically non-
adherent might be those who were not taking the medication for most of the time, 
Current cut-off point of adherence might over-estimate the non-adherence rate. 
Predicting Non-adherence 
The present study indicated that young age (age 21-30), denial of illness 
severity, lithium monotherapy, and being employed were found to be important 
predictors to discriminate the adherent and non-adherent group. The results partly 
support Lee's research (1993) that lithium monotherapy and young age were found to 
be associated with non-adherence. Though chi-square and t-test comparison failed to 
indicate significant difference in medication and age, the mean age of the non-
adherent group (age=37) was observed to be lower than the fully-adherent group 
(age=40). Young patients in Hong Kong with an early onset of illness are observed to 
be more inclined to deny their illness, not to commit the lithium treatment and fail to 
attend blood test (Lee, 1993). Lithium monotherapy was found to be associated with 
non-adherence because the doctors usually held a common belief that a simple dosage 
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regimen would facilitate compliance, and did not usually add a second drug to patients 
who were already non-adherent with the lithium monotherapy (Lee, 1993). Moreover, 
there was another possibility that patielits who were on monotherapy were those of � 
/ 
milder illness. They might be more willing to take the risk of not taking the 
V. 
medication. 
Being employed was found to be an important predictor in discriminating the 
two groups. However, chi-square comparison failed to indicate significant difference 
in the number of patients being employed between the two groups. The number of 
employed patient in non-adherent group (20 patients) was only slightly higher than the 
fully-adherent group (13 patients). On the contrary, housewives and unemployed or 
retired patients tended to be non-adherent. Comparing the distribution of employment 
status showed that among the fully adherent group, 81% of them were in full-
time/part-time employment. From the above distribution, the patients being employed 
tended to be adhering to the lithium treatment regimen. Though no previous study 
indicated relationship between adherence and employment status, Braitman, Counts, 
if 
Davenport, and Zurlinden, et al. (1995) reviewed records o f l 2 9 unemployed and 50 
employed psychiatric patients to determine barriers to employment for both groups. 
Lack of motivation, severe side effects from medication, other miscellaneous issueS， 
physical health problems, and substance abuse were ranked as the most frequent 
barriers to employment. Braitman and colleagues (1995) suggested that symptom 
management might enhance desire to work. Lithium is the primary drug used for 
maintenance treatment ofbipolar disorder. It lessens the duration, frequency, and 
severity of episodes of mania and depression and decreases the risk of subsyndromal 
symptoms between episodes (Hopkins 8c Gelenberg，1994). Patients with good 
adherence to lithium might probably have a better control of the mood state. Thus, the 
motivation to work might be improved. On the other hand, patients who were 
employed also needed the medication to maintain a stable mood for them to function 
better at work. 
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Among the attitude measures, only the denial of illness severity was found to 
be an important predictor in distinguishing the two groups. The non-adherent group 
i 
tended to deny the illness severity. This was consistent to the finding that denial of 
V. 
illness was the most commonly cited reason of partial or total non-adherence (Keck et 
al. 1996). As mentioned before, manic patients may either deny illness, or actively 
resist the need for medication (Kane, 1985). In addition, the social stigma of mental 
illness in Chinese society may cause patients to deny the need ofpsychiatric 
medication. 
Other Variables Associated with Non-adherence 
Longer duration of lithium treatment was found to be associated with non-
adherence in the present study. This is consistent with Kane's (1985) suggestion that 
non-adherence during the long-term prophylactic treatment program is often a 
‘ • . 
function of time. Patients begin to skip or stop medication with the passage of time. 
Past research indicated that longer duration of treatment could be associated with 
lithium non-adherence (Jamison et al. 1979). It is speculated that patients who 
experienced a period of clinical remission might perceive themselves as recovered. 
Thus, they might deny the need for continuous medication treatment. In addition, the 
patients might be reluctant to carry the label of mental illness as it is still highly 
stigmatized in the Hong Kong society. 
Among the attitude measures, the attitude toward the lithium treatment was the 
only variable that could be associated with non-adherence. The more non-adherent 
tended to hold more negative attitudes toward the lithium treatment. Among the 
attitude sub-categories, the attitudes of opposing to continue the lithium treatment 
regimen and the denial of illness severity were found to be associated with non-
adherence. The latter one was found to be an important predictor in discriminating the 
two groups. However, other attitudes such as therapeutic effectiveness of lithium, 
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side effect, difficulty of maintaining pill taking routine,, sub-cultural attitudes opposed 
• 
to drug treatment, and dissatisfaction with factual knowledge oflithium fail to 
associate with non-adherence. This is consistent with the previous local researches � 
i 
that lithium adherence was not affected by the amount of drug knowledge that the 
s, 
patents possessed and side effects (Lee & Wing, 1992; Lee, 1993). 
Inconsistent with expectation, the attribution of mental distress, health locus of 
control and perceived social support failed to have association with the non-
adherence. However, by individually analyzing each non-adherence measure (i.e. 
patient's self-report, family member's report, case psychiatrist's report), the above 
attitude measures were found to be associated with non-adherence. Among the 
attributions of mental distress, the patients who met 3 or more non-adherence criteria 
(i.e. those patient who consistentlyjudged by self, family member, psychiatrist, or 
blood level monitoring as non-adherent) were more likely to attribute stress as the 
cause of mental distress. Non-adherent patients may perceive that their illness is 
solely due to certain life crises or emotional concerns and failed to understand the 
need for and the value of maintenance psychopharmacological treatment once the 
crisis is past or the situation ameliorated (Kane, 1985). 
Inconsistent to Kucera-Bozarth and colleagues' (1982) finding, present study 
failed to find a significant difference in the internal health locus of control between 
the adherent and non-adherent group. Among the three dimensions of health locus of 
control，those patients who werejudged by the family member as fully adherent 
(following the exact dosage everyday) were more likely to hold a powerful others 
locus of control. It is speculated that those patients who hold a powerful others locus 
of control may be more likely to comply to the authority figures' (e.g. doctor or family 
members) suggestion, thus have a better adherence. 
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Among the social support measure, the patients who reported receiving more 
emotional and instrumental supports from the family tended to be perceived by family 
member as more adhering to the lithium regimen. The results indicated family support� 
/ 
to some extent was related to the adherence, though the effect was not strong enough 
� -
to differentiate the two groups. Past study of Ginath, Antonovsky, and Cohen (1983) 
found that psychiatric outpatients who turned to family for help and support in the 
time of stress tended to be adherent. This result probably supported the positive 
relationship between family support and drug adherence. 
Overall speaking, young age, denial of illness severity, being employed, and 
i 
lithium monotherapy were found to be the important predictors in differentiating the 
adherent and non-adherent groups. However, among those predictors, only the denial 
of illness severity was found to be significantly different between the two groups in t-
test/chi-square test. The patients，denial seems to be the most salient factor that 
associated with non-adherence. Psychoeducation to the patients as well as their 
families about the nature the illness and the need of maintenance medication is still 
needed in future. Family should be involved in the caring of the patients as 
Silverstone and Romans (1996) suggested that family member might play a key role to 
recognize the early symptoms of an episode and to seek help for patients who lack 
insight into their condition. 
Clinically, dependent only on routine psychoeducation such as providing 
educational booklet may not be enough in enhancing adherence. Dealing with the 
underlying reasons for denial in a tailor-made manner is more important. Denial itself 
is a complex issue. In the Hong Kong society, the label of mental illness is still highly 
stigmatized. The patients' denial may be related to the fears of rejection and 
stigmatization. Another possibility for denial may be related to the nature of the 
illness. For instance, the patients who experience the remission in symptoms may not 
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see the need for further treatment. The reasons for patients' denial should be further 




Limitations of the Study and Recommendations 
V. 
There are a number of methodological limitations in the present study. First, 
the clinical variables of the present study was based on the self-report ofpatients. 
I i 
Yet, the self-report was not the most reliable and accurate one. Thus, the significant 
relationship between duration of treatment and non-adherence should be interpreted 
with caution. 
Second, the failure to indicate significant difference in certain variables 
between two groups might be related to the small sample size of the study in clinical 
setting. Moreover, it should be noted that the variable that associated with non-
adherence is correlational rather than a causal relationship. 
Third, the clinic setting of the present study might constrain the patients' reply, 
especially in the mental distress explanatory model. The patients might give answers 
which were in favor of the medical model. 
Fourth, the present study based only on paper-and-pencil format could not 
clarify the complex issues such as non-adherence and denial. It might probably miss 
important information, such as their fear of social stigma, and their illness 
experiences, etc. It is recommended that further study should be supplemented with 
qualitative interview to explore their fear of social stigma, attitudes towards 
psychiatric illness, perceived benefit and cost from the treatment. Intensive use of 
qualitative study over time and in naturalistic settings is recommended as non-
adherence problem is more context-dependent and interpersonal experience that 
cannot be studied by paper-and-pencil test alone. 
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Lastly, it is also recommended to further explore the relationship between 
psychiatric morbidity (e.g. rate of relapse and re-hospitalization) with the medication 
non-adherence by follow-up study in one year's time. This may provide us valuable ‘ 
information about the effect of non-adherence in clinical setting. 
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你服用了鋰多久？ 年 / 月 / 
需要長期服藥的病人（例如血壓高、精神科的病人）’在長期服藥的過程當 
偶然未能完全依足醫生的指示服藥‘十分常見的。 
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1 . — — 作 幅 12.— 講野唔淸楚 23. _ 失去活力 
2. 一 幅吐 13.— 記憶力差 2 4 .— 行路不穩 
3 .— _ _ ^ m u 14.— 便秘 2 5 .— 精神唔集中 
4 .— —唔開胃 15.— — 口 乾 2 6 .— 
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坐立不安 
7. 一 — 頭 暈 18. 一 — 心 跳 2 9 .— 暈倒 
8 .— — 腳 腫 19.— _ _體重增加 3 0 .— 手腳僵硬 
9 .— —大頸泡 20.— _ _肌肉抽搐 3 1 .— _ _ 暗 瘡 
10. 一 _ _手震 2 1 .— __^0几肉關節疼痛 3 2 . — _ _手腳無力 
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、 > 常 ’非 
不 常 
、 司 同 
i^ * i§\ 
1 假如我病了 ’我恢復得有多快是由我自己的行爲所決定1.....2......3......4......5 
的。 
2 不管我做什麼’假如我快生病了，就會生病。 1.....2......3......4......5 
3 定期去看醫生’對我來說是避免生病的最佳方法。 1.....2......3......4......5 
4 大多數影饗我健康情況的事件，都是偶然發生的。 1.....2......3......4......5 
5 每當我覺得不舒服，我就會向專業的醫務人員求敎。 1.....2......3......4......5 
6 我的健康由自己掌握。 1.....2......3......4......5 
7 我生病或身體健康與我家人有很大關係。 1.....2......3......4......5 
8 如果我生病，丨責任全在自己。 1.....2......3......4......5 
9 我康復的速禹有多快，運氣從中起了很大的作用。 1.....2......3......4......5 
10醫務人員保證我身體健康。 1.....2......3......4......5 
H 我的身體好大半是行運的關係》 1.....2......3......4......5 
�2影響我健康狀況的主要因素全在我自己的所作所爲。 1.....2......3......4......5 
13 假如我自己小心，我就不會得病。 1.....2......3......4......5 
14 如果我病癒’通常是因爲其他人的悉心照顧。（如醫生、1.....2......3......4......5 
護士、家人、朋友）。 . 
1 5 不管我做什麼總愛生病。 1.....2......3......4......5 
16我身體好似乎是注定如此。 1.....2......3......4......5 







、 丨 ' 常 非 ‘ 
“‘ , 不 常 
i 同 同 1 , 
rer: r ^ 
, 、 ^C \^ iCi_fc> 
J 你能和家人分享自己的感受。 1.....2......3......4......5 
2 家人是你可信的丨頃談對象。 1.....2......3......4......5 
^ 3 如果你與家人談及一些問題’他們會責怪你的。 1.....2......3......4......5 
4 若有好的東西發生在你的身上’你一定會告訴家人的。1.....2......3......4......5 
5 若你不開心’家人是願意傾聽。 - 1.....2......3......4......5 
6 當你與家人傾談時，-他們會儘量了解你的感受。 1….2......3......4......5 
7 你與家人傾談後’你會感覺好些� 1.....2......3..�4......5 
8 家人能給你意見，辩助你如何處理問題。 1.....2......3......4......5 
9 你在常識上有疑難’你會請敎家人。 1.....2……3......4......5 
10若你有金錢上的困難’你會向家人求助。 1.....2......3......4......5 
11 若你在工作上有疑難’你會向家人請敎。 1.....2......3......4......5 
12 若你需要指示到一個地方’你會向家人請敎。 1.....2......3......4......5 
13 若你在健康上有問題’你會告訴家人。 1.....2......3......4......5 
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來來我將餺 將將到到好 對對感感會 我我我我不 
超超. 興興逛 .少份興 
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診斷(diagnosis) "  
問題開始的年歲(&86 0£?『0^6010^561):  















據你所知 現在需要服用多少種藥物（包括鋰(衍^卩工)在內) ？ 種 
需要長期服藥的病人（例如血壓高、精神科的病人）’在長期服藥的過程當《=^ 
偶然未能完全依足醫生的指示服藥是十分常見的’ 
根據你的觀察 可有試過沒有依足指示服藥？ 有 fte 
請問根據你的觀察 在過去一年中，有幾經常未能依足指示服藥 
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